Clinical Trial Podcast

DECEMBER 29, 2022

In this episode, I’m excited for you to learn about Heart Failure Clinical Trials for medical devices. Sonna and her team successfully completed enrollment in an FDA-approved feasibility trial and are now working towards the next phase of their medical product development lifecycle. Our guest today is Sonna Patel-Raman.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Supply 52

Cloudbyz

AUGUST 15, 2024

Randomization and Trial Supply Management (RTSM) play a pivotal role in the successful execution of clinical trials. As the complexity of clinical trials continues to increase, especially with the rise of multi-center, adaptive, and decentralized trials, the need for robust RTSM systems has become more critical than ever.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Compliance 52

The Pharma Data

SEPTEMBER 14, 2020

Supply chain uncertainty is a challenge every clinical supply chain manager wrestles with – stemming from increasing product demand and quality, the growing complexity of clinical trial designs and a lack of visibility in the supply chain. Accelerating your clinical trial supply through digitalization.

Clinical Supply Chain 52

Clinical Supply Chain Clinical Supply Clinical Trials Clinical Trials 52

Client Pharma

DECEMBER 13, 2021

Collaboration provides clinical trial sponsors with access to the world’s most efficient clinical supply processes using a single contract. As a result, global clinical supply and operations teams can now single source their commercial drug requirements by utilizing two best-in-class solution providers.

Clinical Supply 52

Clinical Supply Clinical Trials Clinical Trials Life Science 52

Cloudbyz

MAY 13, 2023

Overview: Clinical site monitoring metrics and Key Performance Indicators (KPIs) are fundamental tools in the realm of clinical trial management. They provide a way to quantify and evaluate critical aspects of a clinical trial’s performance at individual investigative sites.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Compliance 52

VirTrial

DECEMBER 4, 2023

In the fast-paced world of clinical research, Randomization and Trial Supply Management (RTSM) systems play a pivotal role in ensuring the success of trials. Late integration of RTSM means it inherits decisions made upstream in the trial process.

Trials 52

Trials Clinical Trials Clinical Trials Clinical Research 52

VirTrial

DECEMBER 4, 2023

In the fast-paced world of clinical research, Randomization and Trial Supply Management (RTSM) systems play a pivotal role in ensuring the success of trials. Late integration of RTSM means it inherits decisions made upstream in the trial process.

Trials 52

Trials Clinical Trials Clinical Trials Clinical Research 52

VirTrial

DECEMBER 4, 2023

In the fast-paced world of clinical research, Randomization and Trial Supply Management (RTSM) systems play a pivotal role in ensuring the success of trials. Late integration of RTSM means it inherits decisions made upstream in the trial process.

Trials 52

Trials Clinical Trials Clinical Trials Clinical Research 52

VirTrial

DECEMBER 4, 2023

In the fast-paced world of clinical research, Randomization and Trial Supply Management (RTSM) systems play a pivotal role in ensuring the success of trials. Late integration of RTSM means it inherits decisions made upstream in the trial process.

Trials 40

Trials Clinical Trials Clinical Trials Clinical Research 40

The Pharma Data

AUGUST 15, 2021

VTX-801 is a novel investigational gene therapy to be evaluated in a Phase 1/2 clinical trial to determine the safety, tolerability, and pharmacological activity of a single intravenous infusion in adult patients with Wilson Disease. Pfizer is collaborating with Vivet on the clinical supply of VTX-801 for the Phase 1/2 clinical trial.

Gene Therapy 52

Gene Therapy Gene Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 10, 2021

Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed to the development of more than 100 product candidates, of which 27 are currently in clinical development.

Containment 52

Containment Clinical Development Antibody Development 52

The Pharma Data

DECEMBER 4, 2021

company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in clinical trials. (AWS), an Amazon.com, Inc.

Manufacturing 52

Manufacturing Development Drugs Clinical Supply Chain 52

The Pharma Data

JANUARY 24, 2021

Sairiyo is advancing the clinical development of its lead drug candidate, Cepharanthine, a repurposed and reformulated naturally derived compound for the potential treatment of cancer, neurological, inflammatory and infectious diseases. Research and development efforts will be led by Dr. Paul Van Slyke.

Drugs 52

Drugs Containment Development Clinical Development 52

The Pharma Data

OCTOBER 27, 2020

. Molecular Partners, a global leader in the development of DARPin® therapeutics, will be responsible for the conduct of phase 1 & 2 trials that may lead to emergency use approval; Novartis will be responsible for further development, manufacturing, distribution and commercialization.

Development 40

Development Protein Manufacturing Medicine 40

Pharmaceutical Technology

MARCH 20, 2023

Africa has considerable advantages and opportunities for trialling investigational medicinal products that, if pharma companies can correctly harness, will turn the continent into a superpower for clinical trials. Clinical trials data for Africa Globally, research has found that 62.2% being African American, 3.4%

Clinical Trials 130

Clinical Trials Clinical Trials Trials Clinical Supply Chain 130

Pharmaceutical Technology

MAY 23, 2023

The war in Ukraine has had a significant impact on clinical trials in Europe, exacerbating supply chain delays that were already causing multiple problems even before the Covid-19 pandemic intensified the situation. The company operates globally but was founded in Ukraine. We couldn’t put people’s lives at risk.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Clinical Supply Chain 130

XTalks

MARCH 25, 2025

Clinical trials in the US are undergoing rapid transformation in 2025. Driven by advances in digital technology, regulatory updates and growing emphasis on patient-centric design, sponsors and research organizations are rethinking how studies are designed, conducted and analyzed. billion by 2033, indicating a CAGR of 16.84%.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Supply Chain 52